Labs / Assays & in vitro testing

Bambusa Therapeutics
Boston, MA, United States · bambusatx.com
GMP
Bambusa Therapeutics is a clinical-stage biopharmaceutical company based in Boston, Massachusetts and also operating in Victoria, Australia. It develops bispecific antibodies for immunological and inflammatory disorders, with a pipeline spanning atopic dermatitis, Type 2 inflammatory diseases, inflammatory bowel disease, and autoantibody-driven autoimmune disease.
They take quote requests by email.
What they offer
Bispecific antibody discovery and development
Develops next-generation bispecific antibodies for immunological and inflammatory disorders.
Clinical development
Advances lead antibody candidates through clinical development programs.
Preclinical program development
Advances preclinical candidates for inflammatory bowel disease and autoantibody-driven autoimmune disease.
Antibody engineering platform development
Uses an antibody engineering platform with half-life extension and high-concentration subcutaneous delivery.
What they work on
- Modalities
- Antibody, Bispecific, ADC, mRNA, Cell therapy
- Species and models
- E. coli
- Therapeutic areas
- immunology, inflammation, atopic dermatitis, chronic spontaneous urticaria, prurigo nodularis, asthma, food allergy, chronic rhinosinusitis with nasal polyps, chronic obstructive pulmonary disease, inflammatory bowel disease, autoantibody-driven autoimmune disease, gastroenterology
- Sites
- Boston, USA · Victoria, Australia
- Serves
- North America, Australia
- Address
- 22 Boston Wharf Road Floor 7 Boston, MA 02210
- Founded
- 2023
Similar labs. GlycoNex, Inc., Intellective Bio, MYCENAX, ORF Biologics
Found in a contract services directory. Listing built from bambusatx.com. Work here? Claim this listing.